Recent breakthroughs in in-vitro gametogenesis (IVG) have brought the possibility of gene-edited human embryos closer to reality, with CRISPR-Cas9 poised to make
Artificial intelligence research group OpenAI has countersued X owner Elon Musk, escalating a long-standing legal dispute that was prompted when Musk pursued